Corcept Therapeutics reported $126K in Ordinary Share Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Ani Pharmaceuticals ANIP:US $ 0M 0M
Aphria Inc APH:CN C$ 2.08B 830K
Ardelyx ARDX:US $ 0.01M 0M
Aurora Cannabis Inc ACB:CN 6.42B 123K
Biodelivery Sciences International BDSI:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Canopy Growth Corp WEED:CN C$ 7.47B 5.16M
Corcept Therapeutics CORT:US $ 0.13M 0M
Depomed DEPO:US $ 0M 0M
Eleven Biotherapeutics EBIO:US $ 0.2M 0.01M
Eli Lilly And LLY:US $ 598.2M 0.1M
Esperion Therapeutics ESPR:US $ 27K 1000
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Knight Therapeutics Inc GUD:CN C$ 652.68M 15.74M
Lannett LCI:US $ 0.04M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Novartis NOVN:VX SF 901M 12M
Novartis NVS:US $ 901M 12M
Omeros OMER:US $ 625K 1000
Pacira Pharmaceuticals PCRX:US $ 0.04M 0M
Supernus Pharmaceuticals SUPN:US $ 0.05M 0M
Ziopharm Oncology ZIOP:US $ 0.22M 0M